IJR News - today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Congress
Genius — OpenServe
Trending
DPS raises El Paso cold-case reward to $6,000
Texas Ranger Division
— Oct 16, 2026
Reward raised to $6,000 in 1995 killing of Celia Loya, 30, found beaten in her east El Paso home.
+5
0
Share
Burberry reworks signature check with Birtwell florals for 2027 show
Burberry
— Sep 21, 2026
Celia Birtwell, 85, redrew Burberry's check into gingham and stripe with florals and faces for Daniel Lee's SS27 show that closed London Fashion Week.
+9
+2
2
Share
Dana Whitfield
It's clever how they turned the gingham and stripes into something new while keeping the Burberry identity intact.
Uvalde Shooter’s Grandma, 66, Triumphs Over Death After Being Shot, Instantly Reminds World What He Did to Her
Reporting
— Jun 30, 2022
For days, the world thought she was dead — the first of the many that would die on a May day that scarred the community of Uvalde, Texas, forever. But Celia Gonzales, the first person shot by her grandson Salvador Ramos…
0
Share
Ashe County, Oregon and McFarland girls fall in tennis postseason
Sports
— Oct 18, 2026
Girls’ tennis seasons ended across several state and regional tournaments: Ashe County was upset by Pisgah 6-3 in the NCHSAA dual-team playoffs, while Wisconsin state qualifiers from Oregon, Waunakee and McFarland lost their opening-round matches. Waunakee nevertheless finished as a two-time conference champion, and Oregon’s Celia Brink and Hayley Swenson earned a state berth as special qualifiers.
+5
0
Share
IJR
SEC Reportedly Launches Investigation Into Nvidia’s Accounting Practices Just Over A Week After CEO’s Exit
Jack McGeever · 3 min · 16h
Argenx FB102 meets Phase 2 celiac endpoint
Health
— Oct 8, 2026
Argenx Phase 2 FB102 trial in 126 celiac adults met the primary endpoint (Vh:Cd p=0.0176); firm plans Phase 3. Same day it halted the Sjögren's UNITY study.
+4
0
Share
Most Influential Women in World History
Yourlist
— Ranking
From ancient queens who ruled empires to modern activists who changed laws, these women left indelible marks on politics, science, and culture. Vote for who you think shaped history most profoundly.
Share
Argenx Q3 Sales Rise 54% to $1.7B
Forte Group
— Oct 22, 2026
argenx reported third-quarter 2026 sales of $1.7 billion, up 54% year over year, and net income of $506 million, while acquisition-related costs weighed on operating margins and the company expects about $4 billion in 2026 R&D and administrative expenses. It is advancing VYVGART into additional indications—including a pediatric myasthenia gravis application granted FDA priority review—and progressing its broader pipeline, including Phase 3 development of FB102 for celiac disease.
+2
+2
1
Share
Jared Kim
Strong sales growth and solid profits show the company is executing well despite rising costs.
Nationwide Recall Targets Gluten-Free Mixes Over Wheat Gluten
Eat
— Sep 21, 2026
GF Blends is recalling three gluten-free mixes—Truly AIP All Purpose Flour, Truly AIP Bread Mix, and EAT G.A.N.G.S.T.E.R. Flat Bread Pizza Mix—after independent testing found gluten in plantain flour supplied by PMF Global, potentially exposing people with celiac disease or severe gluten intolerance to adverse health effects. The recalled products were sold nationwide online and through retailers, and consumers should discard them or return for a full refund, with the company arranging replacements and providing contact information for questions; no illnesses have been reported to date.
+3
0
Share
Argenx plans $2.2B Forte Biosciences deal
Forte Group
— Jul 27, 2026
Argenx has agreed to acquire Forte Biosciences for about $2.2 billion in cash, offering $77 per Forte share and funded entirely from Argenx’s cash to complete a Q3 2026 closing after standard approvals and tender conditions. The deal adds Forte’s FB102, a first-in-class CD122 antibody for vitiligo and celiac disease with potential broader autoimmune applications, boosting Argenx's immunology pipeline beyond Vyvgart.
+14
0
Share
FDA Requires More Evidence for Ascelia’s Orviglance
Business
— Oct 11, 2026
FDA requires more clinical evidence for Ascelia's Orviglance but said a prospective analysis of existing SPARKLE images with a different primary endpoint could support approval.
+3
0
Share
FaithTap
Harden Scores 51, Passes Bryant in 50-Point Games
James Harden scored 51 points to lead Cleveland past Indiana 128-119, recording his 26th career 50-point game and moving past Kobe Bryant for third on the NBA’s all-time list. Cavaliers coach Kenny Atkinson called Harden a top-10 player in
1h · 3 reads
Share
Ascelia Completes FDA Meeting on Orviglance
Health
— Sep 8, 2026
Biopharma firms report a mix of regulatory progress: Ascelia Pharma advances its Orviglance NDA with an FDA Type A meeting held and minutes due in about 30 days, while AstraZeneca secures FDA approval for Etcamah (camizestrant) after an advisory panel opposed it earlier, signaling a potential shift in benefit-risk assessment. Ascletis Pharma launches a US Phase I trial for ASC36 obesity drug under an IND, highlighting ongoing development in metabolism therapies alongside expectations of further data and pricing implications for investors.
+2
0
Share